← Browse by Condition
Medical Condition
acute myeloid leukemia in remission
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT06440135 Phase 1
Recruiting
Ziftomenib Maintenance Post Allo-HCT
Enrollment
22 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT05917405 Phase 2
Recruiting
Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
Enrollment
302 pts
Location
France
Sponsor
Nantes University Hospital